TechNation

Invest.com Launches ‘Hedge Fund for the People’ With $20m in Backing

Orbimed raises $307 million for Israel-dedicated VC fund | Zebra raises $12 million for automated medical diagnosis | Demisto exits stealth mode, raises $6 million for cyber-security

Dreamstime

Invest.com launches ‘hedge fund for the people’ with $20m in backing 

Three years after buying the domain name invest.com, Israeli tech investor Moshe Hogeg is launching a “hedge fund for the people” backed by $20 million in investment capital from his Singularteam venture capital fund and other, unnamed investors. Launched in Britain, the new site will offer investors seven alternative investment strategies, which it said are “similar to those employed by quant hedge funds.” Invest.com’s portfolio management service requires a minimum investment of 1,500 pounds ($8,500) for a customized portfolio, with the investor’s risk appetite determined by questions posed by a robo-adviser and trades conducted automatically. “Alternative investments is an asset class that has seen extremely high growth in recent years, more than doubling in size since 2005. However, hedge funds and many other alternative investments have typically been very elitist – available only to very wealthy investors,” said Ophir Gertner, its founder. Invest.com plans to launch in Germany, Italy, Russia, Asia and the Middle East and add several new alternative investment products by the end of next year. (TheMarker Staff)

Orbimed raises $307 million for Israel-dedicated VC fund

OrbiMed, a U.S.-based investor in healthcare technology, said this week it had raised $307 million for its second Israel-focused venture capital fund. OrbiMed Israel Partners II will invest in about 20 biopharmaceutical, digital health, medical devices and diagnostics startups in Israel and may co-invest with OrbiMed’s global private equity team, which has $15 billion under management. “Israel is a compelling locus of life sciences innovation, on par with top regions in the U.S. and Europe,” commented Jonathan Silverstein, co-head of OrbiMed’s global private equity effort.  OrbiMed’s Israel office was opened in 2010, and is led by Dr. Nissim Darvish, Erez Chimovits and Anat Naschitz. Its first fund raised $222 million and invested in 17 startups, among them cCam Bioteherapeutics, which is developing immunotherapies for cancer and was sold to Merck, and Applied Immune Technologies, which is developing therapeutic and diagnostic applications for cancer, viral and autoimmune diseases. (Eliran Rubin)

Zebra raises $12 million for automated medical diagnosis

Israel’s Zebra Medical Vision, which uses artificial intelligence to enable computers to read and diagnose medical images, said this week it had raised $12 million in a funding round led by Utah-based healthcare provider Intermountain Healthcare. Zebra said it would also collaborate with Intermountain to accelerate development of new imaging algorithms to improve patient care. Its current algorithms are used in the fields of bone health, cardiovascular analysis, liver and lung indications. Founded in 2014 by Eyal Toledano, Eyal Gura and Elad Benjamin, Zebra has built a database of CT-scans and MRIs used to teach computers how to read images and diagnose bone, cardiovascular analysis, liver and lung indications. Existing investors, including Salesforce.com co-founder Marc Benioff, joined the round. (Eliran Rubin)

Demisto exits stealth mode, raises $6 million for cyber-security

Demisto, a U.S.-Israel cyber security startup, emerged from stealth mode on Wednesday and said it had raised $6 million from the U.S. venture fund Accel and private investors. Demisto allows computer-security personnel to communicate with each other and move across different cyber security products when their network is under attack, enabling them to respond faster and more efficiently. It also provides a smart bot to automatically address standard house-cleaning activities around security, a feature that should help companies struggling to fund enough qualified personal for security tasks. Demisto was launched last July and counts 17 employees, 13 in its Tel Aviv research and development center and the rest in sales and marketing based in an office in Cupertino, California. Its founders are CEO Slavik Markovich, Marketing Vice President Rishi Bhargava, Products Vice President Dan Sarel and Engineering Vice President Guy Rinat. (Eliran Rubin)